Check your product against every target market at once — a regulation-traced verdict in 60 seconds, not weeks. Catch the blockers before they delay your launch.
Same ingredient. Different regimes. Different answers.
One ingredient across five regimes, side by side. Green is a cited permission. Red is a cited block. A dash is Marco declining to answer — and naming what is still yours to verify.
Read from the same registers a check reads. Where a register has no row, that is what it says — absence is not permission.
One product clears four gates before anyone can buy it. Most brands stall at a different one than they expect.
You can't cost a product you don't know is legal — and the answer is a consultant, a fee and a fortnight.
Ingredient, dose, market. A cited verdict in one pass.
The factory that quotes fastest is rarely the one that can make it to the verdict you were just given.
Vetted suppliers, matched to that verdict.
See the supplier networkSupplements are a high-risk merchant category. Acquirers can't tell a clean operator from a claims-pusher, so everyone is priced as the worst one.
Freight, payments and testing partners — with your compliance record as the underwriting evidence.
See what is joiningA shelf full of products and no way for a buyer to tell which of them was ever checked.
A storefront where the verdict travels with the product.
TGA reissued the Permissible Ingredients Determination — dose limits re-ingested across 5,000+ ingredients.
Ingredient limitsA DOU retificação quietly moved ANVISA's creatine cap from 3 g to 5 g per day, eight days after IN 373/2025.
Dose cap correctionHealth Canada updated NHP monograph dose caps — folded into every Canadian verdict.
Monograph updateStart free — 4 checks, no card. Every verdict comes cited, or it comes honest.
Team plans & full details on the pricing page.